Invictus Robotic Navigation Instruments

K232044 · Alphatec Spine, Inc. · OLO · Oct 6, 2023 · Neurology

Device Facts

• Record ID: K232044
• Device Name: Invictus Robotic Navigation Instruments
• Applicant: Alphatec Spine, Inc.
• Product Code: OLO · Neurology
• Decision Date: Oct 6, 2023
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 882.4560
• Device Class: Class 2

Intended Use

The Invictus Robotic Navigation Instruments are indicated for use during the placement of Invictus Spinal Fixation System modular screws in either open or minimally invasive procedures. The Invictus Robotic Navigation Instruments are specifically designed for use with Globus Medical's Excelsius GPS® Robotic Navigation Platform, which is intended for use as an aid for precisely locating anatomical structures and for the spatial positioning and orientation of an instrument holder or quide tube to be used by surgeons for navigating and/or quiding compatible surgical instruments in open or percutaneous procedures, provided that the required fiducial markers and rigid patient anatomy can be identified on CT scans or fluoroscopy.

Device Story

Invictus Robotic Navigation Instruments are reusable surgical instruments designed for compatibility with Globus Medical's Excelsius GPS® Robotic Navigation Platform. Instruments facilitate precise placement of Invictus Spinal Fixation System modular screws during open or minimally invasive spinal surgery. System utilizes CT or fluoroscopy data to identify fiducial markers and patient anatomy; robotic platform provides spatial positioning and orientation for instrument holder or guide tube. Surgeons operate instruments to navigate and guide compatible hardware. Device output assists surgeon in anatomical localization and hardware placement, potentially improving surgical accuracy. Instruments are provided non-sterile and require end-user cleaning and steam sterilization.

Clinical Evidence

No clinical data. Substantial equivalence is based on bench testing, including dimensional analysis, geometric comparison, and evaluation of cleaning and reprocessing protocols.

Technological Characteristics

Reusable, non-sterile surgical instruments designed for steam sterilization. Function as navigation aids for robotic-assisted spinal surgery. Design and materials are equivalent to predicate devices. No active electronic components; mechanical instruments interface with the Excelsius GPS® Robotic Navigation Platform.

Indications for Use

Indicated for use during placement of Invictus Spinal Fixation System modular screws in open or minimally invasive spinal procedures. Designed for use with Globus Medical's Excelsius GPS® Robotic Navigation Platform for locating anatomical structures and guiding surgical instruments, provided fiducial markers and patient anatomy are identifiable on CT or fluoroscopy.

Regulatory Classification

Identification

A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.

Predicate Devices

• E-GPS Navigated Instruments (K220862)
• EXCELSIUS GPS® (K171651)
• Invictus® Bone Cement, Invictus Spinal Fixation System (K221926)

Reference Devices

• Arsenal Spinal Fixation System (K161363)

Submission Summary (Full Text)

{0}------------------------------------------------

October 6, 2023

Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

Alphatec Spine, Inc. Unnati Bhuptani Sr. Regulatory Affairs Specialist 1950 Camino Vida Roble Carlsbad, California 92008

### Re: K232044

Trade/Device Name: Invictus Robotic Navigation Instruments Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: Class II Product Code: OLO Dated: July 6, 2023 Received: July 10, 2023

### Dear Unnati Bhuptani:

We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).

{1}------------------------------------------------

Your device is also subject to, among other requirements, the Quality System (QS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review. the OS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

Shumaya Ali-S

Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## Indications for Use

Submission Number (if known)

K232044

Device Name

Invictus Robotic Navigation Instruments

Indications for Use (Describe)

The Invictus Robotic Navigation Instruments are indicated for use during the placement of Invictus Spinal Fixation System modular screws in either open or minimally invasive procedures. The Invictus Robotic Navigation Instruments are specifically designed for use with Globus Medical's Excelsius GPS® Robotic Navigation Platform, which is intended for use as an aid for precisely locating anatomical structures and for the spatial positioning and orientation of an instrument holder or quide tube to be used by surgeons for navigating and/or quiding compatible surgical instruments in open or percutaneous procedures, provided that the required fiducial markers and rigid patient anatomy can be identified on CT scans or fluoroscopy.

Type of Use (Select one or both, as applicable)

> Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# K232044 510(k) Summary

Image /page/3/Picture/1 description: The image shows the logo for Atec. The logo is a stylized wordmark with the first letter, 'a', in green and the rest of the letters in dark blue. There is a horizontal line underneath the wordmark.

Traditional 510(k) Premarket Notification Invictus Robotic Navigation Instruments

This 510(k) summary of safety and effectiveness is being submitted in accordance with the requirements of 21 CFR 807.92.

| I. | SUBMITTER: | Alphatec Spine, Inc.<br>1950 Camino Vida Roble<br>Carlsbad, CA 92008<br>Phone: [phone]<br>Fax: [phone] |
|-----|------------------------|----------------------------------------------------------------------------------------------------------------------|
| | Contact Person: | Unnati Bhuptani<br>Sr. Regulatory Affairs Specialist |
| | Date Summary Prepared: | September 12, 2023 |
| II. | DEVICE | |

| Trade or Proprietary Name: | Invictus Robotic Navigation Instruments |
|----------------------------|-----------------------------------------|
| Common Name: | Navigation Instruments |
| Classification Name: | Orthopedic Stereotaxic Instrument |
| Regulation Number: | 21 CFR 882.4560 |
| Classification: | Class II |
| Product Code: | OLO |

#### LEGALLY MARKETED PREDICATE DEVICES III.

### Primary Predicate Device:

| 510(k) | Product Name | Clearance Date |
|---------|-----------------------------|----------------|
| K220862 | E-GPS Navigated Instruments | July 14, 2022 |

### Additional Predicate Devices:

| 510(k) | Product Name | Clearance Date |
|---------|-----------------------------------------------------------|-------------------|
| K171651 | EXCELSIUS GPS® | August 16, 2017 |
| K221926 | Invictus® Bone Cement, Invictus Spinal Fixation<br>System | December 20, 2022 |

### Reference Devices:

| 510(k) | Product Name | Clearance Date |
|---------|--------------------------------|----------------|
| K161363 | Arsenal Spinal Fixation System | June 10, 2016 |

{4}------------------------------------------------

Image /page/4/Picture/0 description: The image shows the logo for "atec". The "a" is green, and the "tec" is dark blue. There is a horizontal line underneath the logo.

#### IV. DEVICE DESCRIPTION

The Invictus Robotic Navigation Instruments are surgical instruments that is designed to be compatible with Globus Medical's Excelsius GPS® Robotic Navigation Platform. The subject device is intended to facilitate the placement of screws during spinal surgery. The subject device are reusable instruments and offered non-sterile to be cleaned and steam sterilized by the end user.

#### V. INDICATIONS FOR USE

The Invictus Robotic Navigation Instruments are indicated for use during the placement of Invictus Spinal Fixation System modular screws in either open or minimally invasive procedures. The Invictus Robotic Navigation Instruments are specifically designed for use with Globus Medical's Excelsius GPS® Robotic Navigation Platform, which is intended for use as an aid for precisely locating anatomical structures and for the spatial positioning and orientation of an instrument holder or guide tube to be used by surgeons for navigating and/or guiding compatible surgical instruments in open or percutaneous procedures, provided that the required fiducial markers and rigid patient anatomy can be identified on CT scans or fluoroscopy.

#### VI. TECHNOLOGICAL COMPARISON TO PREDICATES

The subject Invictus Robotic Navigation Instruments have equivalent technological characteristics to that of the predicate devices and the minor differences do not raise any new issues of the safety and effectiveness. Specifically, the following characteristics are similar between the subject and predicates:

- Device design and dimensions
- . Indications for Use
- Materials of manufacture
- Principles of Operation ●

Identical to the predicates, the subject Invictus Robotic Navigation Instruments are also non-sterile, reusable instruments to be steam sterilized by the end user.

The technological design features of the subject instrument were compared to the predicates in intended use, indications for use, design, function and technology and it was demonstrated that they are substantially equivalent.

#### Clinical Information

Not applicable; determination of substantial equivalence is not based on an assessment of clinical performance data.

{5}------------------------------------------------

Image /page/5/Picture/0 description: The image shows the logo for "atec". The "a" is green, while the "tec" is dark blue. There is a trademark symbol next to the "c". A black line is underneath the logo.

#### VII. PERFORMANCE DATA

The Invictus Robotic Navigation Instruments have been evaluated through a dimensional analysis and geometric comparison to the predicate devices to establish the safety and effectiveness for accuracy performance.

The subject Invictus Robotic Navigation Instruments were compared to the predicate/reference devices and found to be substantially equivalent to the predicate/reference devices in terms of cleaning and reprocessing.

The results of this engineering analysis show that the subject is substantially equivalent to the cleared predicate.

#### VIII. CONCLUSION

Based upon the information provided in this 510(k) submission, it has been determined that the subject device is substantially equivalent to legally marketed devices in regard to indications for use, intended use, design, technology, and performance.